The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 02, 2024

Filed:

Aug. 04, 2022
Applicant:

Thomas Jefferson University, Philadelphia, PA (US);

Inventors:

Masahiro Iwamoto, Villanova, PA (US);

Maurizio Pacifici, Philadelphia, PA (US);

Assignee:

Thomas Jefferson University, Philadelphia, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/192 (2006.01); A61K 31/185 (2006.01); A61K 31/19 (2006.01); A61K 31/415 (2006.01); A61K 35/12 (2015.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/192 (2013.01); A61K 31/185 (2013.01); A61K 31/19 (2013.01); A61K 31/415 (2013.01); A61K 35/12 (2013.01); A61K 45/06 (2013.01);
Abstract

The invention provides methods for muscle repair or regeneration comprising administering therapeutically effective amounts of RAR agonists or stem cells that are pretreated with contact with a RAR agonist to a subject at a site of muscle damage. Additionally, the invention provides compositions comprising RAR agonist treated stem cells and methods of use of said cells for muscle repair or regeneration. In one embodiment, the stem cells are mesenchymal stem cells. In one embodiment, the RAR agonist is an RARγ agonist. In one embodiment, administration of the RAR agonist is begun during a period of increased endogenous retinoid signaling in the subject resulting from incurrence of the damaged muscle tissue.


Find Patent Forward Citations

Loading…